1.18.23 | Maternal Health
PRGLAC Then and Now: Where We Are and Where We’re Going
During this congressional briefing and national webinar, designed specifically for—but not limited to—members of the 118th Congress, panelists reviewed the state of PRGLAC, the PRGLAC recommendations and their implementation status and the current legislative and regulatory landscape.
1.18.23 | Research and Clinical Trials
Friends of ORWH Congressional Reception
The Friends of the Office of Research on Women’s Health invite you to a congressional reception in celebration of Women’s […]
1.5.23 | Maternal Health
Pregnant and Lactating Populations in Research: How Leaving These Populations Out Leaves Them Behind
During this congressional briefing and national webinar, panelists explored certain areas of research where the exclusion of these groups has resulted in an inability to support them, how federal research investments could improve outcomes, and where there is opportunity—both at the legislative and regulatory level—moving forward.
12.13.22 | Policy
Reps. Castor, Fitzpatrick, and Underwood Introduce Legislation to Promote Greater Inclusion of Pregnant and Lactating Women in Research
Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduced H.R. 9487, the Advancing Safe Medications for Moms and Babies Act of 2022 on December 13, 2022.
11.16.22 | Maternal Health
NICHD’s Role in Advancing Research on Pregnant and Lactating Populations
Dr. Diana Bianchi gave remarks on NICHD’s role in advancing research in pregnant and lactating populations during an October meeting of the Coalition to Advance Maternal Therapeutics (CAMT).
11.8.22 | Maternal Health
Addressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research
During this virtual congressional briefing and national webinar, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research, how to ensure the appropriate inclusion of these populations, and the current state of this type of inclusion in research, both within the federal government and the corporate sector.
10.27.22 | Policy
SWHR’s 2022 Health Care Value Assessment Principles
In 2019, SWHR conceived a set of principles to help ensure value frameworks and assessments reflected factors relevant to women […]
